METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS.
D000963:Antimetabolites; D000970:Antineoplastic Agents; D035843:Biomedical Research; D001774:Blood Chemical Analysis; D003880:Dermatology; D005762:Gastroenterology; D006146:Guanidines; D006801:Humans; D007938:Leukemia; D007942:Leukemia, Experimental; D007948:Leukemia, Monocytic, Acute; D007951:Leukemia, Myeloid; D008935:Mitoguazone; D011765:Pyruvaldehyde; D014116:Toxicology
D000963:Antimetabolites; D000970:Antineoplastic Agents; D006146:Guanidines; D011765:Pyruvaldehyde; D008935:Mitoguazone
ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; BLOOD CHEMICAL ANALYSIS; CLINICAL RESEARCH; DERMATOLOGY; GASTROENTEROLOGY; GUANIDINES; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOCYTIC; TOXICOLOGIC REPORT